Regnology Enters into Exclusive Talks to Acquire Invoke
Regnology, a leading software provider with a focus on regulatory reporting solutions, announces today it expects to sign a definitive agreement to acquire Invoke, a French-based provider of financial, regulatory, and tax reporting solutions for supervisory authorities, and reporting entities. On completion of the agreement, the deal would mark the fifth acquisition in less than a year for Regnology.
With 160+ full-time employees, Invoke serves over 1,800 regulated entities and supervisory authorities throughout Europe with its XBRL-based banking, insurance, and tax reporting solutions. Invoke’s corporate tax solution will complement Regnology’s financial tax reporting solution and open a new growth area for the company.
Rob Mackay, CEO of Regnology, comments: “The round of recent deals we have undertaken, culminating with today’s announcement, sets Regnology on an accelerated path for growth internationally. Invoke’s advanced solutions would complement our technology stack while its team’s deep knowledge of the French and Luxembourg markets, in particular, would strengthen our ability to deliver superior RegTech and tax reporting solutions on a wider scale.”
The contemplated acquisition would follow on the heels of Regnology’s acquisition of UK-based statistical SDMX reporting specialist Metadata Technology earlier this month. This strategic deal was preceded by the purchase of KPMG’s K-Helix reporting software business unit and the acquisition of Brussels-based reporting specialist b-fine in November 2022. In June 2022, Regnology announced a deal to acquire PwC UK’s Tax Information Reporting (TIR) software business.
“The acquisition of Vizor in 2021 was the founding step for the advent of Regnology. Combined with our organic growth, our M&A activity over the past 12 months continues to supercharge our business, significantly accelerating our international expansion and consolidating our RegTech and SupTech offering into a powerful integrated regulatory reporting platform,” said Bobby Rahman, Head of M&A for Regnology.
“We were impressed by the momentum of Invoke over the past two years under Raphael’s leadership. The proposed acquisition of Invoke would bring Regnology closer than ever to realizing our vision of providing the global community of regulators and regulated financial institutions with best-in-class, end-to-end solutions that can solve regulatory complexity with better data quality and unlock unprecedented efficiencies,” added Mackay.
Raphael de Talhouet, CEO of Invoke continued: “This proposed deal could come as a natural leap forward for Invoke. Regnology shares the same entrepreneurial vision and innovation focus ISAI Expansion and Sagard NewGen had when they acquired Invoke in 2021. Our regulatory and tax expertise, local knowledge, and advanced solutions would be a natural fit for Regnology, and we believe a combination would offer amazing growth opportunities.”
The contemplated acquisition is subject to further due diligence and conditions including information and consultation with Invoke’s works council, agreeing and executing any definitive agreement.
About Regnology
Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 34,000 financial institutions, 60 regulators, international organizations and tax authorities relying on our solutions, we’re uniquely positioned to bring greater data quality, efficiency and cost savings to all market participants. With over 850 employees in 15 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes. Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology.
For more information about Regnology, connect with us on LinkedIn and Twitter.
Visit our website: www.regnology.net
About Invoke
Invoke is a French-based software vendor specializing in SaaS solutions dedicated to financial, tax and regulatory reporting. A leading player in the field of French tax management for large and mid-sized companies, Invoke has also established itself as a SaaS leader in RegTech and SupTech in Europe due to its innovative solutions for regulatory reporting and prudential supervision.
It’s cutting-edge expertise, particularly in XBRL and inline XBRL technologies, makes Invoke a preferred partner for national and supranational supervisory authorities, as well as for banks, insurers and company groups required to comply with national and European regulatory requirements, including CRD V, Solvency II and ESEF.
As an EDI partner of the French tax authority, (DGFiP), a founding member of XBRL France and a direct member of XBRL International, Invoke currently supports 1,800 customers in 34 countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230529005204/en/
Contact information
Mireille Adebiyi
Chief Marketing Officer, Regnology
mireille.adebiyi@regnology.net
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
I-care Becomes a Unicorn23.12.2025 10:45:00 CET | Press Release
I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
